Form 4: Verizon Executive Kyle Malady Sells 10,000 Shares of Common Stock

EVP and Group CEO of Verizon Business, Kyle Malady, sold 10,000 shares of Verizon Communications Inc. common stock at an average price of $43.024 on April 24, 2025.

Summary

• On April 24, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 10,000 shares of common stock.
• The sale was executed at a weighted average price of $43.024 per share, with individual transactions ranging from $43.021 to $43.035.
• Following the transaction, Malady directly owns 26,508 shares of common stock and indirectly owns 18,412 shares through a 401(k).
• Malady also holds 375,492.429 shares of phantom stock through a deferred compensation plan.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the buying and selling activities of company executives. It's important for investors to monitor these filings, although a single sale doesn't necessarily indicate a negative outlook on the company's future.

Comparison to Industry Standards

• Executive stock sales are common and are often part of compensation packages.
• Comparing Malady's transactions to those of executives at similar companies like AT&T (T) or T-Mobile (TMUS) could provide context.
• The amount of phantom stock held is also a typical component of executive compensation plans in large corporations.

Stakeholder Impact

• The stock sale could have a minor, short-term impact on shareholders if it influences the stock price, but it's unlikely to be significant given the volume.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Verizon, VZ, Kyle Malady, stock sale, Form 4, executive compensation, phantom stock, insider trading